Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 43,687 shares at $28.95 ($1.3M) on 2016-05-02, disclosed to the SEC on 2016-05-04.
Open-market sale of $1.3M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.95 | 35,438 | $1.0M | 80.8% |
| 2 | $29.59 | 8,249 | $244K | 19.2% |
| Total | $29.07 avg | 43,687 | $1.3M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |